Search results
Earnings call: Harmony Biosciences maintains strong growth, eyes future launches By Investing.com
Investing.com· 4 days agoHarmony Biosciences (ticker: HRMY) has reported a solid start to the year with a 30% increase in...
Trump Is Now Raging at His Own Lawyer—and Wrecking a Big MAGA Fantasy
The New Republic via Yahoo News· 3 days agoTrump also promoted a video of Fox’s Jeanine Pirro insisting that it showcases his ability to...
Alkermes plc Reports First Quarter 2024 Financial Results
WFRV 5 Green Bay· 3 days agoAlkermes plc (Nasdaq: ALKS) today reported financial results for the first quarter of 2024. With these new data now in hand, we plan to initiate a phase 2 study in narcolepsy type 2 in the second half of 2024.
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 days agoHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q1 2024 Earnings Call Transcript April 30, 2024...
Alkermes' (ALKS) Q1 Earnings & Revenues Fall Shy of Estimates
Zacks via Yahoo Finance· 2 days agoRecent Updates Last month, Alkermes announced positive top-line data from a phase Ib study...
Earnings call: Alkermes reports solid Q1 2024 results, optimistic about pipeline By Investing.com
Investing.com· 3 days agoThe neuroscience company reported net sales for VIVITROL at $97.7 million, ARISTADA at $78.9...
'North Korea vibes': Fox News slammed for 'cult' narrative about Trump's criminal trial
The Raw Story· 3 days agoFox News commentators have flipped reality on its head to paint a "cult" like narrative about former...
Alkermes plc Completes Sale of Athlone, Ireland Facility to Novo Nordisk
WFRV 5 Green Bay· 2 days agoAlkermes plc (Nasdaq: ALKS) has completed the previously announced sale of its development and manufacturing facility in Athlone, Ireland to Novo Nordisk. In connection with the closing of the ...
Analyst Report: Jazz Pharmaceuticals plc
Morningstar Research via Yahoo Finance· 1 day agoJazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic ...
Needham raises Harmony Biosciences stock target on growth strategy By Investing.com
Investing.com· 3 days ago(NASDAQ: NASDAQ:HRMY) to $52, up from the previous $50, while maintaining a Buy rating on the stock....
